THE SURVIVAL RATE OF LC IS 15.5%.
THAT’S UNACCEPTABLE. WE’RE
HERE TO CHANGE THAT.

 

Cancer – The New Frontier: Alive two years on, thanks to new drug

dmxaa.jpgDr McKeage was running a clinical trial using an experimental drug on non-small cell lung cancer patients like Mr Torrens.

The drug was DMXAA, developed at the Auckland Cancer Society Research Centre by Professors Bruce Baguley and Bill Denny.

 

Trackback

 

Leave a Reply